Lexeo Therapeutics, Inc. (LXEO) insider trading.
In Q3 2026, insiders at Lexeo Therapeutics, Inc. reported 14 non-derivative transactions on 11 Forms 3, 4 and 5: 0 open-market purchases and 7 sales worth $300K.
- Transactions
- 14
- Purchases (P)
- 0
- Sales (S)
- 7
- Net shares, P minus S
- -66,326
- Insiders
- 4
- Last filed
- 2026-09-28
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Townsend Richard Nolan | Director, Officer · Chief Executive Officer | 4 | 0 | 2 |
| Otero Jose Manuel | Officer · Chief Operating Officer | 4 | 0 | 2 |
| Bhalla Narinder Pal | Officer · Chief Medical Officer | 3 | 0 | 1 |
| Tamayo Louis Edward | Officer · Chief Financial Officer | 3 | 0 | 2 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-14 | Townsend Richard Nolan | A (A) | 2,306 | $2.64 | 376,778 | Form 4 |
| 2026-09-14 | Otero Jose Manuel | A (A) | 2,110 | $2.64 | 138,288 | Form 4 |
| 2026-09-14 | Bhalla Narinder Pal | A (A) | 2,714 | $3.58 | 84,908 | Form 4 |
| 2026-08-18 | Townsend Richard Nolan | S (D) | 3,345 | $4.95 | 374,472 | Form 4 |
| 2026-08-18 | Otero Jose Manuel | S (D) | 1,304 | $4.96 | 136,178 | Form 4 |
| 2026-08-18 | Tamayo Louis Edward | S (D) | 4,117 | $4.91 | 92,907 | Form 4 |
| 2026-07-01 | Townsend Richard Nolan | S (D) | 25,947 | $4.48 | 377,817 | Form 4 |
| 2026-07-01 | Otero Jose Manuel | S (D) | 4,666 | $4.48 | 137,482 | Form 4 |
| 2026-07-01 | Tamayo Louis Edward | S (D) | 4,641 | $4.49 | 97,024 | Form 4 |
| 2026-07-01 | Bhalla Narinder Pal | S (D) | 22,306 | $4.42 | 82,194 | Form 4 |
| 2026-06-29 | Townsend Richard Nolan | A (A) | 67,000 | $0 | 403,764 | Form 4 |
| 2026-06-29 | Otero Jose Manuel | A (A) | 12,060 | $0 | 142,148 | Form 4 |
| 2026-06-29 | Tamayo Louis Edward | A (A) | 12,000 | $0 | 101,665 | Form 4 |
| 2026-06-29 | Bhalla Narinder Pal | A (A) | 55,000 | $0 | 104,500 | Form 4 |
Transaction codes in this quarter
Get LXEO insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1907108&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · LXEO company page · Lexeo Therapeutics, Inc. on SEC.gov
Questions
Are insiders buying or selling Lexeo Therapeutics, Inc. (LXEO)?
In Q3 2026, insiders at Lexeo Therapeutics, Inc. reported 14 non-derivative transactions on 11 Forms 3, 4 and 5: 0 open-market purchases and 7 sales worth $300K. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Lexeo Therapeutics, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/lxeo.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.